The findings showed that multiple cancer-related pathways, such as “bladder cancer”, “glioma”, “pancreatic cancer”, “colorectal cancer”, “small cell lung cancer”, “thyroid cancer”, “renal cell carcinoma” and “p53 signaling pathway” were enriched in DCP1A high expression group. This evidence concerns the gene TP53 and thyroid cancer.